Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

China · Delayed Price · Currency is CNY

19.54

+0.17 (0.88%)

May 20, 2026, 1:25 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Generic drug APIs and intermediates	2.22B	1.99B	2.00B	2.35B	1.96B
Generic drug APIs and intermediates Growth	11.42%	-0.53%	-14.69%	19.66%	-21.20%
CDMO APIs and Intermediates	391.90M	365.80M	405.66M	263.08M	557.24M
CDMO APIs and Intermediates Growth	7.13%	-9.83%	54.20%	-52.79%	552.65%
Preparations	418.00M	254.76M	105.03M	33.97M	3.97M
Preparations Growth	64.07%	142.56%	209.20%	754.85%	-
other	29.36M	16.13M	11.84M	19.62M	19.88M
other Growth	81.97%	36.26%	-39.66%	-1.29%	103.22%
Total	3.06B	2.63B	2.53B	2.67B	2.55B
Total Growth	16.36%	4.10%	-5.23%	4.78%	-1.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Overseas	1.63B	1.72B	1.82B	1.86B	1.85B
Overseas Growth	-5.19%	-5.55%	-2.45%	0.71%	-1.35%
China	1.43B	914.11M	709.76M	803.49M	695.04M
China Growth	56.82%	28.79%	-11.66%	15.60%	-2.40%
Total	3.06B	2.63B	2.53B	2.67B	2.55B
Total Growth	16.36%	4.10%	-5.23%	4.78%	-1.64%

Source: S&P Global Market Intelligence.